A Phase IB/II Open-Label Trial of Tisotumab Vedotin HuMax-TF-ADC Monotherapy and in Combination with Other Agents in Subjects with Recurrent or Stage IVB Cervical Cancer

Brief Summary

Type:
Cervical

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03786081

Study #:
STUDY00143379

Start Date:
Apr 21, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03786081

View Complete Trial Details & Eligibility at ClinicalTrials.gov